Evaluation of mutagenic potential of mold extracts isolated from buildings using the mouse lymphoma thymidine kinase gene mutation assay [MLA]

• Autorzy: Arkusz J , Stepnik M. , Stanczyk M. , Lewinska D. , Gutarowska B. , Piotrowska M.
• Języki publikacji: EN

Abstrakty

EN

In recent years interest in mycotoxin-producing fungi growing in indoor environments has increased. Evidence of mutagenic potential of some molds or their mycotoxins is still equivocal. Much more informa­tion is available for single mycotoxins or their metabolites than for complex mixtures composed of different fungi products. The aim of this study was to identify the mutagenic potential of extracts isolated from mold-attacked buildings using the mouse lymphoma assay (MLA). Although a thin-layer chromatography analysis ofextracts isolated from test buildings showed the presence of well known mycotoxins (ochratoxin A and sterigmatocystin), the test extracts as well as control extracts did not reveal mutagenic potential after 3-hr exposure without or with metabolic activation as tested with MLA. Negative results were also obtained after 24-hr treatment with every test sample in the absence of S9 fraction. The data indicates that extracts prepared from control and test buildings under experimental conditions did not induce mutations affecting the expression of the thymidine kinase gene in the cultured L5178Y TK+/- cells.

• Wydawca: -
• Czasopismo: Polish Journal of Environmental Studies
• Rocznik: 2007
• Tom: 16
• Numer: 6
• Strony: 807-815
• Opis fizyczny: p.807-815,ref.

Twórcy

autor

Arkusz J

• Nofer Institute of Occupational Medicine, sw.Teresy 8, 91-348 Lodz, Poland

autor

Stepnik M.

autor

Stanczyk M.

autor

Lewinska D.

autor

Gutarowska B.

autor

Piotrowska M.

Bibliografia

• 1. HARDIN B. D., KELMAN B. J., SAXON A. Adverse hu­man health effects associated with molds in the indoor envi­ronment. J Occup Environ Med. 45, 470, 2003.
• 2. EZEONU I. M., PRICE D. L., SIMMONS R. B., CROW S. A., AHEARN D. G. Fungal production of volatiles dur­ing growth on fiberglass. Appl Environ Microbiol. 60, 4172, 1994.
• 3. GRAVESEN S. Identification and prevalence of cultur- able mesophilic microfungi in house dust from 100 Danish homes. Comparison between airborne and dust-bound fungi. Allergy. 33, 268, 1978.
• 4. VAN LOO J. M., ROBBINS C. A., SWENSON L., KEL­MAN B. J. Growth of mold on fiberglass insulation building materials—a review of the literature. J Occup Environ Hyg. 1, 349, 2004.
• 5. HIIPAKKA D. W., BUFFINGTON J. R. Resolution of sick building syndrome in a high-security facility. Appl Occup Environ Hyg. 15, 635, 2000.
• 6. ROBBINS C. A., SWENSON L. J., NEALLEY M. L., GOTS R. E., KELMAN B. J. Health effects of mycotoxins in indoor air: a critical review. Appl Occup Environ Hyg. 15, 773, 2000.
• 7. SCHULZ T., SENKPIEL K., OHGKE H. Comparison of the toxicity of reference mycotoxins and spore extracts of com­mon indoor moulds. Int J Hyg Environ Health. 207, 267, 2004.
• 8. IARC (International Agency for Research on Cancer). Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Report of an IARC Working Group. IARC, Lyon. 56, p.489, 1993.
• 9. DVORACKOVA I., STORA C., AYRAUD N. Evidence of aflatoxin B1 in two cases of lung cancer in man. J Cancer Res Clin Oncol. 100, 221, 1981.
• 10. HAYES R. B., VAN NIEUWENHUIZE J. P., RAATGEVER J. W., TEN KATE F. J. Aflatoxin exposures in the industrial setting: an epidemiological study of mortality. Food Chem Toxicol. 22, 39, 1984.
• 11. OLSEN J. H., DRAGSTED L., AUTRUP H. Cancer risk and occupational exposure to aflatoxins in Denmark. Br J Cancer. 58, 392, 1988.
• 12. SCOTT P. M., STOLTZ D. R. Mutagens produced by Alter­naria alternata. Mutat Res. 78, 33, 1980.
• 13. SCHRADER T. J., CHERRY W., SOPER K., LANGLOIS I., VIJAY H. M. Examination of Alternaria alternata muta­genicity and effects of nitrosylation using the Ames Salmo­nella test. Teratog Carcinog Mutagen. 21, 261, 2001.
• 14. LOARCA-PINA G., KUZMICKY P. A., DE MEJIA E. G., KADO N. Y. Inhibitory effects of ellagic acid on the direct- acting mutagenicity of aflatoxin B1 in the Salmonella micro­suspension assay. Mutat Res. 398, 183, 1998.
• 15. DE GROENE E. M., JAHN A., HORBACH G. J., FINK- GREMMELS J. Mutagenicity and genotoxicity of the mycotoxin ochratoxin A. Environ. Toxicol. Pharmacol. 1, 21, 1996.
• 16. FOLLMANN W., LUCAS S. Effects of the mycotoxin och­ratoxin A in a bacterial and a mammalian in vitro mutagenic­ity test system. Arch Toxicol. 77, 298, 2003.
• 17. FLANNIGAN B., SAMSON R. A., MILLER J. D. (eds). Microorganisms in Home and Indoor Work Environments, U.K., Harwood Academic, 2001.
• 18. FRISVAD J. C., FILTENBORG O., THRANE U., LUND F. Screening methods for secondary metabolites produced by fungi in pure culture. In: SAMSON R. A., HOEKSTRA E. S., FRISVAD J. C., FILTENBORG O. (Eds) Introduction to food-borne fungi., CBS, Baarn Delft, pp.235-242, 1996.
• 19. SAMSON R. A., HOEKSTRA E. S., FRISVAD J. C., FILTENBORG O. Introduction to food-borne fungi. 5th Edn., CbS, Baarn, The Netherlands, 1996.
• 20. AMES B. N., MCCANN J., YAMASAKI E. Methods for detecting carcinogens and mutagens with the Salmonella typhimurium microsome mutagenicity test. Mutat Res. 31, 347, 1975.
• 21. LOWRY O. H., ROSENBROUGH N. J., FARR A. L. AND RANDALL R. J., Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265, 1951.
• 22. OECD Guideline 476, OECD Guidelines for the Testing of Chemicals, Section 4-Health Effects. In vitro Mammalian Cell Gene Mutation Test, OECD, Paris, 1997.
• 23. CLEMENTS J. The mouse lymphoma assay. Mutat Res. 455, 97, 2000.
• 24. JOHANNING E., BIAGINI R., HULL D., MOREY P., JAR- VIS B., LANDSBERGIS P. Health and immunology study following exposure to toxigenic fungi (Stachybotrys charta­rum) in a water-damaged office environment. Int Arch Oc­cup Environ Health. 68, 207, 1996.
• 25. HODGSON M. J., MOREY P., LEUNG W. Y., Morrow L., Miller D., Jarvis B. B., Robbins H., Halsey J. F., Storey E. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med. 40, 241, 1998.
• 26. PEPELJNJAK S., SLOBODNJAK Z., SEGVIC M., PERA- ICA M., PAVLOVIC M. The ability of fungal isolates from human lung aspergilloma to produce mycotoxins. Hum Exp Toxicol. 23, 15, 2004.
• 27. CHULZE S. N., MAGNOLI C. E., DALCERO A. M. Oc­currence of ochratoxin A in wine and ochratoxigenic mycoflora in grapes and dried vine fruits in South America. Int J Food Microbiol. 111 (Suppl 1), S5, 2006.
• 28. IARC (International Agency for Research on Cancer). Some naturally occurring substances. IARC monographs on the evaluation of carcinogenic risks to humans, IARC, Lyon. 40, p.245, 1976.
• 29. ZEPNIK H., PAHLER A., SCHAUER U., AND DEKANT W. Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? Toxicol Sci 59, 59, 2001.
• 30. OBRECHT-PFLUMIO S., CHASSAT T., DIRHEIMER G., MARZIN D. Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney mi­crosomes. Mutat Res. 446, 95, 1999.
• 31. HENNING A., FINK-GREMMELS J., LEISTNER L. Mu­tagenicity and effects of ochratoxin A on the frequency of sister chromatid exchanges after metabolic activation. In: CASTEGNARO M., PLESTINA R., DIRHEIMER G., CHERNOZEMSKY I. N., BARTSCH H. (eds) Mycotoxins, endemic nephropathy and urinary tract tumors, IARC Scien­tific Publications. IARC, Lyon. 115, pp. 255-260, 1991.
• 32. LIU G. T., QIAN Y. Z., ZHANG P., DONG Z. M., SHI Z. Y., ZHEN Y. Z., MIAO J., XU Y. M. Relationships between Alternaria alternata and oesophageal cancer. IARC Sci Publ. 105, 258, 1991.
• 33. XU D. S., KONG T. Q. AND MA J. Q., The inhibitory effect of extracts from Fructus lycii and Rhizoma polygonati on in vitro DNA breakage by alternariol, Biomed. Environ. Sci. 9, 67, 1996.
• 34. LIU G. T., QIAN Y. Z., ZHANG P., DONG W. H., QI Y. M., GUO H. T. Etiological role of Alternaria alternata in human esophageal cancer, Chin. Med. J. 105, 394, 1992.
• 35. DAVIS V.M. AND M.E. STACK, Evaluation of alternariol and alternariol methyl ether for mutagenic activity in Sal­monella typhimurium, Appl. Environ. Microbiol. 60, 3901, 1994.
• 36. BRUGGER E. M., WAGNER J., SCHUMACHER D. M., KOCH K., PODLECH J., METZLER M., LEHMANN L. Mutagenicity of the mycotoxin alternariol in cultured mam­malian cells. Toxicol Lett. 164, 221, 2006.
• 37. SCHUMACHER D. M., METZLER M., LEHMANN L. Mutagenicity of the mycotoxin patulin in cultured Chinese hamster V79 cells, and its modulation by intracellular glutathione. Arch Toxicol. 79, 110, 2005.
• 38. SOMMER N. F., BUCHANAN J. R., AND FORTLAGE R. J. Production of Patulin by Penicillium expansum. Appl Mi­crobiol. 28, 589, 1974.
• 39. ESCOULA L. Patulin production by Penicillium granula- tum and inhibition of ruminal flora. J Environ Pathol Toxicol Oncol. 11, 45, 1992.
• 40. IARC (International Agency for Research on Cancer). Some naturally occurring and synthetic food components, furo- coumarins and ultraviolet radiation. In: Monographs on the evaluation of the carcinogenic risk to humans, IARC, Lyon. 40, pp.83-98, 1986.
• 41. WURGLER F. E., FRIEDERICH U., SCHLATTER J. Lack of mutagenicity of ochratoxin A and B, patulin and cnestine in Salmonella typhimurium TA 102. Mutat Res. 261, 209, 1991.
• 42. UMEDA M., TSUTSUI T., SAITO M. Mutagenicity and inducibility of DNA single-strand breaks and chromosome aberrations by various mycotoxins. Gann 68, 619, 1977.
• 43. LIU B. H., YU F. Y., WU T. S., Li S. Y, SU M. C., WANG M. C., SHIH S. M. Evaluation of genotoxic risk and oxida­tive DNA damage in mammalian cells exposed to mycotoxins, patulin and citrinin. Toxicol Appl Pharmacol. 191, 255, 2003.
• 44. NUNEZ F., RODRIGUEZ M. M., BERMUDEZ M. E., CORDOBA J. J., ASENSIO M. A. Composition and toxi- genic potential of the mold population on dry-cured Iberian ham. Int J Food Microbiol. 32, 185, 1996.
• 45. MACHOVA E., KOGAN G., CHORVATOVICOVA D., SANDULA J. Ultrasonic depolymerization of the chitin- glucan complex from Aspergillus niger and antimutagenic activity of its product. Ultrason Sonochem. 6, 111, 1999.
• 46. KRIZKOVA L., DURACKOVA Z., SANDULA J., SLA- MENOVA D., SASINKOVA V., SIVONOVA M., KRAJCO- VIC J. Fungal beta-(1-3)-D-glucan derivatives exhibit high antioxidative and antimutagenic activity in vitro. Anticancer Res. 23, 2751, 2003.
• 47. YIANNIKOURIS A., ANDRE G., POUGHON L., FRAN­COIS J., DUSSAP C. G., JEMINET G., BERTIN G., JOUANY J. P. Chemical and conformational study of the interactions involved in mycotoxin complexation with beta- D-glucans. Biomacromolecules. 7, 1147, 2006.
• 48. OBRECHT-PFLUMIO S., DIRHEIMER G. In vitro DNA and dGMP adducts formation caused by ochratoxin A. Chem Biol Interact. 127, 29, 2000.
• 49. MCKEAN C., TANG L., TANG M., BILLAM M., WANG Z., THEODORAKIS C. W., KENDALL R. J., WANG J. S. Comparative acute and combinative toxicity of aflatoxin B(1) and fumonisin B(1) in animals and human cells. Food Chem Toxicol. 44, 868, 2006.
• 50. CLIVE D., BOLCSFOLDI G., CLEMENTS J., COLE J., HOMNA M., MAJESKA J., MOORE M., MULLER L., MYHR B., OBERLY T., et al. Consensus agreement regard­ing protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ Mol Mutagen. 25, 165, 1995.